Latest Articles
Adenomyosis Independently Increases Risk for Endometrial Proliferative Disorders - Oncology Nurse Advisor
Adenomyosis Independently Increases Risk for Endometrial Proliferative Disorders Oncology Nurse Advisor
Published: May 4, 2026, 4 a.m.
Circulating Tumor DNA in Ovarian Cancer: Emerging Roles in Early Detection, Risk Stratification, and Disease Monitoring.
Early diagnosis of ovarian cancer remains one of the most important unmet needs in gynecologic oncology because survival is strongly stage-dependent and most patients still present with disseminated disease. Conventional …
Published: April 21, 2026, midnight
Five Under 5: Top Oncology Videos for the Week of 4/12 - OncLive
Five Under 5: Top Oncology Videos for the Week of 4/12 OncLive
Published: April 19, 2026, 10:58 a.m.
Trial Marks “Major Step in Progress in Endometrial Cancer Research” - Oncology News Central
Trial Marks “Major Step in Progress in Endometrial Cancer Research” Oncology News Central
Published: April 16, 2026, 10:14 a.m.
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma - Oncology Nursing News
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma Oncology Nursing News
Published: April 15, 2026, 4:59 p.m.
Dr. Pothuri Discusses Emerging ADCs in HER2-Expressing Endometrial Cancer - Targeted Oncology
Dr. Pothuri Discusses Emerging ADCs in HER2-Expressing Endometrial Cancer Targeted Oncology
Published: April 14, 2026, 5:46 p.m.
SGO 2026 – GSK bucks the B7-H4 trend | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
SGO 2026 – GSK bucks the B7-H4 trend | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: April 13, 2026, 12:32 p.m.
SGO 2026 – BioNTech’s Enhertu me-too comes up short | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
SGO 2026 – BioNTech’s Enhertu me-too comes up short | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: April 13, 2026, 10:30 a.m.
Unravelling Multilayered RNA Modification Networks in Female Reproduction and Obstetric/Gynaecologic Disorders.
Background/Objective: RNA modifications, including N6-methyladenosine (m6A), 5-methylcytosine (m5C), 7-methylguanosine (m7G), N1-methyladenosine (m1A), pseudouridine (Ψ), N4-acetylcytidine (ac4C), 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) and adenosine-to-inosine (A-to-I) editing, constitute a critical layer of post-transcriptional regulation that …
Published: April 13, 2026, midnight
New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer - StreetInsider
New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer StreetInsider
Published: April 10, 2026, 11:01 a.m.
Link copied to clipboard!